Osteoporosis Canada is aware of the following recent media releases

1. The reported potential link between esophageal cancer and bisphosphonate use.

• Information on bisphosphonate use and esophageal cancer

2. The reported potential link between calcium supplement intake and vascular events.

• Information for patients (PDF)
  
• Information for health professionals (PDF)

3. The reported link between a high annual dose of vitamin D and falls and fractures.

• OC Response to JAMA's 2010 study, Annual High-Dose Oral Vitamin D and Falls and Fractures in Older Women (PDF)
  
• Information for people living with osteoporosis - COPN responds to the JAMA study (PDF)

4. The reported potential link between atypical fractures and bisphosphonates.

• Information on atypical fractures and bisphosphonates (PDF)

5. The reported potential link between Fosamax and atrial fibrillation.

• Information on Fosamax and atrial fibrillation (PDF)

6. The reported potential link between oral bisphosphonates and aseptic osteonecrosis.

• Information for people living with osteoporosis (PDF)
  
• Information for health care professionals (PDF)

7. The reported potential link on the Osteonecrosis of the Jaw.

• Information on bisphosphonates and the Osteonecrosis of the Jaw (ONJ)

8. The reported potential link between use of zoledronic acid (Aclasta) and renal impairment.

• Information on zoledronic acid (Aclasta) and renal impairment.

Patients are advised to consult with their physicians concerning their individual situations if they have any questions or concerns.